Quality Standard:【产品介绍】Serotonin (5-hydroxytryptamine, 5-HT),
a neurotransmitter, elicits a wide array of
physiological effects by binding to several
receptor subtypes, including the 5-HT2 family of
seven-transmembrane-spanning, G-protein-coupled
receptors, which activate phospholipase C and D
signaling pathways. HTR2C is the 2C subtype of
serotonin receptor and its mRNA is subject to multiple
RNA editing events, where genomically encoded
adenosine residues are converted to inosines. RNA editing
is predicted to alter amino acids within the
second intracellular loop of the 5-HT2C receptor
and generate receptor isoforms that differ in their
ability to interact with G proteins and the activation
of phospholipase C and D signaling cascades, thus
modulating serotonergic neurotransmission in the
central nervous system. Studies in humans have
reported abnormalities in patterns of HTR2C editing
in depressed suicide victims (1).
Recommended Applications
WB
Applications and Recommended Dilution Factors
WB: 1:1,000 - 10,000
Species Reactivity *
Human, Mouse, Rat
*Species cross-reactivity is based on WB analysis.
Products Data
Western blot analysis on (A) SH-SY5Y, (B) BxPC-3,
(C) Molt-4, (D) mouse kidney, and (E) rat kidney
lysates using anti-HTR2C RabMAb (cat. #5315-1).
Specificity
A synthetic peptide corresponding to residues near
the C-terminus of human HTR2C was used as an immunogen.